Organ dysfunction and muscular disability in myotonic dystrophy type 1

Medicine

Volumn 90, Issue 4, 2011, Pages 262-268

  Kaminsky, Pierre ^a,d   Poussel, Mathias ^a,b,e   Pruna, Lelia ^a   Deibener, Joëlle ^a   Chenuel, Bruno ^a,b,e   Brembilla Perrot, Béatrice ^c  

^a CHU NANCY BRABOIS   (France)

^b Laboratoire d'Explorations Fonctionnelles Respiratoires   (France)

^c Department of Cardiologie ^*  (France)

^d Centre de Référence Neuromusculaire   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CATARACT; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTRIGLYCERIDEMIA; LUNG DISEASE; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MUSCLE DISEASE; MYOTONIC DYSTROPHY; OBESITY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; METABOLIC DISEASES; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; PREVALENCE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79959793220     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318226046b     Document Type: Article

References (39)

1. Aitkens S, Kilmer DD, Wright NC, McCrory MA. Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil. 2005;86:1030-1036. (Pubitemid 40692374)
2. Antonini G, Giubilei F, Mammarella A, Amicucci P, Fiorelli M, Gragnani F, Morino S, Ceschin PV, Fragola PV, Gennarelli M. Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats. Neurology. 2000;55:1207-1209.
3. Ashizawa T, Hejtmancik JF, Liu J, Perryman MB, Epstein HF, Koch DD. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet. 1992;42:55-60.
4. Badano L, Autore C, Fragola PV, Picelli A, Antonini G, Vichi R, Cannata D. Left ventricular myocardial function in myotonic dystrophy. Am J Cardiol. 1993;71:987-991. (Pubitemid 23118074)
5. Begin P, Mathieu J, Almirall J, Grassino A. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med. 1997;156:133-139. (Pubitemid 27293178)
6. Begin R, Bureau MA, Lupien L, Bernier JP, Lemieux B. Pathogenesis of respiratory insufficiency in myotonic dystrophy: the mechanical factors. Am Rev Respir Dis. 1982;125:312-318. (Pubitemid 12190638)
7. Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004;147:224-227. (Pubitemid 38176820)
8. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol. 2009;25:e23Ye27.
9. Cudia P, Bernasconi P, Chiodelli R, Mangiola F, Bellocci F, Dello Russo A, Angelini C, Romeo V, Melacini P, Politano L, Palladino A, Nigro G, Siciliano G, Falorni M, Bongiorni MG, Falcone C, Mantegazza R, Morandi L. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry. 2009;80:790-793.
10. Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord. 2005;15:5-16. (Pubitemid 41556627)
11. de Backer M, Bergmann P, Perissino A, Gottignies P, Kahn RJ. Respiratory failure and cardiac disturbances in myotonic dystrophy. Eur J Intensive Care Med. 1976;2:63-67.
12. de Saint Pol T. Evolution of obesity by social status in France, 1981-2003. Econ Human Biol. 2009;7:398-404.
13. Finsterer J, Gharehbaghi-Schnell E, Stollberger C, Fheodoroff K, Seiser A. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet. 2001;59:350-355. (Pubitemid 32451974)
14. Finsterer J, Stollberger C, Blazek G, Kunafer M, Prager E. Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder. Int J Cardiol. 2007;119:176-184. (Pubitemid 46818518)
15. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256-1258.
16. Gilmartin JJ, Cooper BG, Griffiths CJ, Walls TJ, Veale D, Stone TN, Osselton JW, Hudgson P, Gibson GJ. Breathing during sleep in patients with myotonic dystrophy and non-myotonic respiratory muscle weakness. Q J Med. 1991;78:21-31.
17. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008;358:2688-2697. (Pubitemid 351860861)
18. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002;13:444-448. (Pubitemid 34494263)
19. Harper PS, Monckton DG. Myotonic dystrophy. In: Engel AG, Franzini-Amstrong C, eds. Myology. Basic and Clinical. Vol. II. 3rd ed. New York: McGraw-Hill; 2005:1039-1076.
20. Jammes Y, Pouget J, Grimaud C, Serratrice G. Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve. 1985;8:586-594. (Pubitemid 16121859)
21. Johansson A, Boman K, Cederquist K, Forsberg H, Olsson T. Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy. J Intern Med. 2001;249:503-510. (Pubitemid 32823858)
22. Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F. Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath. 2010;14:19-24.
23. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol. 2002;40:1645-1652. (Pubitemid 35253643)
24. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K. Myotonic dystrophy mutation: an unstable CTG repeat in the 3¶ untranslated region of the gene. Science. 1992;255:1253-1255.
25. Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Begin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology. 1997;49:1646-1650. (Pubitemid 28015132)
26. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658-1662. (Pubitemid 29220644)
27. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56:336-340. (Pubitemid 32144144)
28. Mathieu J, De Braekeleer M, Prevost C, Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology. 1992;42:203-208.
29. Matsumura T, Iwahashi H, Funahashi T, Takahashi MP, Saito T, Yasui K, Iyama A, Toyooka K, Fujimura H, Shinno S. A cross-sectional study for glucose intolerance of myotonic dystrophy. J Neurol Sci. 2009;276:60-65.
30. McCrory MA, Wright NC, Kilmer DD. Nutritional aspects of neuromuscular diseases. Phys Med Rehabil Clin N Am. 1998;9:127-143. (Pubitemid 28134024)
31. Melacini P, Villanova C, Menegazzo E, Novelli G, Danieli G, Rizzoli G, Fasoli G, Angelini C, Buja G, Miorelli M, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol. 1995;25:239-245.
32. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, Swanson MS, Thornton CA. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet. 2009;18:1471-1481.
33. Osborne RJ, Thornton CA. RNA-dominant diseases. Hum Mol Genet. 2006;15(Spec 2):R162YR169. (Pubitemid 44446789)
34. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA. 2004;101:7088-7093. (Pubitemid 38596447)
35. Reardon W, MacMillan JC, Myring J, Harley HG, Rundle SA, Beck L, Harper PS, Shaw DJ. Cataract and myotonic dystrophy: the role of molecular diagnosis. Br J Ophthalmol. 1993;77:579-583. (Pubitemid 23281459)
36. Sabovic M, Medica I, Logar N, Mandic E, Zidar J, Peterlin B. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Neuromuscul Disord. 2003;13:822-826. (Pubitemid 37532732)
37. Shieh K, Gilchrist JM, Promrat K. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. Muscle Nerve. 2010;41:197-201.
38. Sovari AA, Bodine CK, Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiol Rev. 2007;15:191-194. (Pubitemid 46956454)
39. Zifko UA, Hahn AF, Remtulla H, George CF, Wihlidal W, Bolton CF. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain. 1996;119:1911-1922. (Pubitemid 27032623)